NO2006013I2 - Humant parathyreoidahormon (Humant parathyroid hormon) - Google Patents

Humant parathyreoidahormon (Humant parathyroid hormon)

Info

Publication number
NO2006013I2
NO2006013I2 NO2006013C NO2006013C NO2006013I2 NO 2006013 I2 NO2006013 I2 NO 2006013I2 NO 2006013 C NO2006013 C NO 2006013C NO 2006013 C NO2006013 C NO 2006013C NO 2006013 I2 NO2006013 I2 NO 2006013I2
Authority
NO
Norway
Prior art keywords
parathyroid hormone
human parathyroid
human
ultrapure
hormone
Prior art date
Application number
NO2006013C
Other languages
English (en)
Other versions
NO2006013I1 (no
Original Assignee
Nps Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24840399&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2006013(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nps Pharma Inc filed Critical Nps Pharma Inc
Publication of NO2006013I1 publication Critical patent/NO2006013I1/no
Publication of NO2006013I2 publication Critical patent/NO2006013I2/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Glass Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO2006013C 1991-05-23 2006-10-24 Humant parathyreoidahormon (Humant parathyroid hormon) NO2006013I2 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/707,114 US5208041A (en) 1991-05-23 1991-05-23 Essentially pure human parathyroid hormone

Publications (2)

Publication Number Publication Date
NO2006013I1 NO2006013I1 (no) 2006-11-06
NO2006013I2 true NO2006013I2 (no) 2009-12-07

Family

ID=24840399

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19922000A NO304190B1 (no) 1991-05-23 1992-05-21 Rent parathyroid hormon, fremgangsmÕte for dets fremstilling samt farmasoytisk sammensetning inneholdende det
NO2006013C NO2006013I2 (no) 1991-05-23 2006-10-24 Humant parathyreoidahormon (Humant parathyroid hormon)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO19922000A NO304190B1 (no) 1991-05-23 1992-05-21 Rent parathyroid hormon, fremgangsmÕte for dets fremstilling samt farmasoytisk sammensetning inneholdende det

Country Status (16)

Country Link
US (1) US5208041A (no)
EP (1) EP0515228B1 (no)
JP (1) JP2563726B2 (no)
KR (1) KR970007755B1 (no)
AT (1) ATE164394T1 (no)
CA (1) CA2068438C (no)
DE (1) DE69224858T2 (no)
DK (1) DK0515228T3 (no)
ES (1) ES2115642T3 (no)
FI (1) FI106802B (no)
HK (1) HK1004340A1 (no)
IE (1) IE921672A1 (no)
IL (3) IL101829A (no)
NO (2) NO304190B1 (no)
NZ (1) NZ242855A (no)
ZA (1) ZA923735B (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420242A (en) * 1986-10-22 1995-05-30 Kaare M. Gautvik Production of human parathyroid hormone from microorganisms
USRE37919E1 (en) 1989-05-12 2002-12-03 The General Hospital Corporation Recombinant DNA method for production of parathyroid hormone
TW273513B (no) * 1993-10-27 1996-04-01 Chugai Pharmaceutical Co Ltd
US5763416A (en) 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
US5962427A (en) 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
US6074840A (en) 1994-02-18 2000-06-13 The Regents Of The University Of Michigan Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)
US20020193338A1 (en) * 1994-02-18 2002-12-19 Goldstein Steven A. In vivo gene transfer methods for wound healing
US5942496A (en) 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
EP1007673B1 (en) 1997-07-30 2008-12-17 Emory University Novel bone mineralization proteins, dna, vectors, expression systems
US7923250B2 (en) 1997-07-30 2011-04-12 Warsaw Orthopedic, Inc. Methods of expressing LIM mineralization protein in non-osseous cells
US6770623B1 (en) 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
AR033639A1 (es) 1998-08-19 2004-01-07 Lilly Co Eli Uso de hormonas paratiroideas para preparar medicamentos para reducir el riesgo de fracturas oseas vertebrales o no vertebrales en seres humanos con riesgo de padecer o que padecen osteoporosis
US6495662B1 (en) * 1998-10-22 2002-12-17 The General Hospital Corporation Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)
WO2000032771A1 (en) 1998-11-30 2000-06-08 The General Hospital Corporation Pth1r and pth3r receptors, methods and uses thereof
US7820393B2 (en) * 1999-01-14 2010-10-26 Scantibodies Laboratory, Inc. Methods, kits and antibodies for detecting parathyroid hormone
US6689566B1 (en) 1999-01-14 2004-02-10 Scantibodies Laboratory, Inc. Methods, kits, and antibodies for detecting parathyroid hormone
WO2004028444A2 (en) * 1999-06-02 2004-04-08 Scantibodies Laboratory, Inc. Parathyroid hormone antagonists and uses thereof
US20080108086A1 (en) * 1999-06-02 2008-05-08 Cantor Thomas L Parathyroid hormone antagonists and uses thereof
AU7734800A (en) * 1999-09-29 2001-04-30 General Hospital Corporation, The Polypeptide derivatives of parathyroid hormone (pth)
US7087248B2 (en) 2000-06-30 2006-08-08 Daiichi Asubio Pharma Co., Ltd. Pharmaceutical component based on human parathyroid hormone and a pharmaceutical composition for intranasal administration comprising the component
US6387711B1 (en) * 2000-08-11 2002-05-14 Quest Diagnostics Investments Incorporated Liquid intact parathyroid hormone (PTH) standards
US6905886B2 (en) * 2000-08-11 2005-06-14 Quest Diagnostics Investments Incorporated Preservative solutions
AU2002339843B2 (en) * 2001-07-23 2007-12-06 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
US20040067526A1 (en) * 2002-10-03 2004-04-08 Cantor Thomas L. Methods for diagnosing and guiding treatment of bone turnover disease
EP1610813A4 (en) * 2003-03-19 2009-07-01 Gen Hospital Corp CONFORMATION RESTRICTED PARATHORMONE WITH A HELIX STABILIZERS
KR100540659B1 (ko) * 2003-07-02 2006-01-10 삼성전자주식회사 이미지 확대 인쇄 방법과 장치 및 컴퓨터 프로그램을저장하는 컴퓨터로 읽을 수 있는 기록 매체
JP4871128B2 (ja) 2003-07-17 2012-02-08 ザ ジェネラル ホスピタル コーポレイション 高次構造的に制約された副甲状腺ホルモン（ｐｔｈ）アナログ
AU2005244734A1 (en) 2004-05-13 2005-12-01 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
US7541140B2 (en) * 2004-06-03 2009-06-02 Scantibodies Laboratory, Inc. Assessing risk for kidney stones using parathyroid hormone agonist and antagonist
CN101355959B (zh) * 2005-11-10 2013-02-27 密歇根理工大学管理委员会 黑熊甲状旁腺素和使用黑熊甲状旁腺素的方法
US8143374B2 (en) * 2006-08-04 2012-03-27 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (PTH)
MX353986B (es) 2007-08-01 2017-11-06 Massachusetts Gen Hospital Metodos de analisis y seleccion usando receptores acoplados a proteina g y composiciones relacionadas.
BRPI0721943A2 (pt) * 2007-08-09 2014-03-18 Usv Ltd Processo ortogonal para purificação do hormônio da paratireoide humano recombinante (rhpth) (1-34)
PL2464655T3 (pl) * 2009-08-11 2017-08-31 Biocon Limited Procesy chromatograficzne
CA2782640A1 (en) 2009-12-07 2011-06-16 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
JP5941040B2 (ja) 2010-05-13 2016-06-29 ザ ジェネラル ホスピタル コーポレイション 副甲状腺ホルモン類似体およびその使用
ES2833277T3 (es) * 2011-06-07 2021-06-14 Asahi Kasei Pharma Corp Preparación liofilizada que contiene PTH de alta pureza y método para producirla
CN102993293B (zh) * 2012-12-05 2014-05-07 深圳翰宇药业股份有限公司 一种特立帕肽醋酸盐的纯化方法
LU100168B1 (en) 2017-04-12 2018-10-15 Michael Pazianas Prevention of Bone and Mineral Disorders by Restoring Calcium and Phosphate Homeostasis in Patients Suffering from Chronic Kidney Disease
WO2021195877A1 (en) 2020-03-30 2021-10-07 Sichuan Luzhou Buchang Bio-Pharmaceutical Co., Ltd. Formulations of human parathyroid hormone (pth) and methods for producing same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886132A (en) * 1972-12-21 1975-05-27 Us Health Human parathyroid hormone
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
AU6448990A (en) * 1989-09-29 1991-04-28 Her Majesty in Right of Canada, as represented by National Research Council Canada Synthesis of mature human parathyroid hormone

Also Published As

Publication number Publication date
IL119840A0 (en) 1997-03-18
DK0515228T3 (da) 1998-09-28
ATE164394T1 (de) 1998-04-15
DE69224858D1 (de) 1998-04-30
ZA923735B (en) 1993-01-27
AU1604992A (en) 1993-03-11
AU639856B2 (en) 1993-08-05
CA2068438A1 (en) 1992-11-24
EP0515228B1 (en) 1998-03-25
NO922000D0 (no) 1992-05-21
FI922356A0 (fi) 1992-05-22
NO304190B1 (no) 1998-11-09
IL119840A (en) 2005-08-31
JPH0687897A (ja) 1994-03-29
NO922000L (no) 1992-11-24
IL101829A0 (en) 1992-12-30
HK1004340A1 (en) 1998-11-20
DE69224858T2 (de) 1998-07-23
FI106802B (fi) 2001-04-12
FI922356L (fi) 1992-11-24
NZ242855A (en) 1994-04-27
EP0515228A2 (en) 1992-11-25
NO2006013I1 (no) 2006-11-06
CA2068438C (en) 1996-11-12
ES2115642T3 (es) 1998-07-01
EP0515228A3 (no) 1994-05-04
IL101829A (en) 1999-12-31
JP2563726B2 (ja) 1996-12-18
IE921672A1 (en) 1992-12-02
KR970007755B1 (en) 1997-05-16
US5208041A (en) 1993-05-04

Similar Documents

Publication Publication Date Title
NO2006013I2 (no) Humant parathyreoidahormon (Humant parathyroid hormon)
DE3680997D1 (de) Einrichtung zur als sprache empfundenen rueckkopplung.
FI881652A7 (fi) Isoelektrinen fokusointimenetelmä ja laite mainitun menetelmän suorittamiseksi
KR850004664A (ko) 자연어에 의한 지적가이던스방법(知的 guidence 方法) 및 그 장치
ATE72833T1 (de) Rinder-prowachstums- und -wachstumshormon.
DE3778438D1 (de) Referenzspannung fuer transistorkonstantstromquelle.
DE3682249D1 (de) Verfahren zur bildbearbeitung und geraet zur bilderzeugung.
DK0489116T3 (da) Fusionsproteiner omfattende GM-CSF og IL-3
NO901026L (no) Anordning og fremgangsmaate for naturlig spraakanalysering.
ATE78590T1 (de) Probennehmer.
IT8721658A0 (it) Dispositivo e metodo immunodiagnostico.
DE3853301D1 (de) Verfahren und Vorrichtung zur Positionierung von Vorlagen in Bildabtastern.
DE3685043D1 (de) Linsenmessgeraet und messverfahren dazu fuer gleitsichtlinsen.
DE3662077D1 (de) A lorgnette frame
ATE148923T1 (de) Funktioneller test und reagenz zur bestimmung von fibrinogen
DE3778483D1 (de) Vorrichtung fuer linearlager mit vollstaendiger nachstellung und entsprechendes verfahren.
GR851623B (no)
IT8467198A1 (it) Metodo e dispositivo per il controllo dei processi di saldatura mediante l'analisi della luminosita' generata durante il processo.
NO860381L (no) Fremgangsmaate og anordning for bildebehandling.
IT1136664B (it) Rivealtore termoionico a fiamma modificata per gas-cromatografi,e metodo di identificazione di componenti in un campione sotto analisi
FR2714768B1 (fr) Dispositif de balayage électronique à lentille active et source illuminatrice intégrée.
IT8721387A0 (it) Procedimento e dispositivo per infilare uno stoppino in uno stiratoio in funzione.
DE69018538D1 (de) Verfahren und Gerät zur Steuerprogrammentwicklung.
FI905985L (fi) Menetelmä somatotropiinien saamiseksi liukoisiksi ja naturoimiseksi käyttämällä alhaista urean konsentraatiota
FR2592525B1 (fr) Procede de fabrication d'un transistor lateral integre et circuit integre le comprenant

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: SHIRE-NPS PHARMACEUTICALS, US